Danaher Corporation $DHR Stock Sold by Telos Capital Management Inc.

Telos Capital Management Inc. reduced its stake in Danaher Corporation (NYSE:DHR) by 7.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,772 shares of the conglomerate’s stock after selling 3,780 shares during the period. Telos Capital Management Inc.’s holdings in Danaher were worth $9,698,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Gunderson Capital Management LLC acquired a new stake in shares of Danaher during the 3rd quarter valued at $765,000. EP Wealth Advisors LLC bought a new stake in Danaher during the 2nd quarter worth $3,807,000. Frank Rimerman Advisors LLC increased its holdings in Danaher by 181.9% in the 3rd quarter. Frank Rimerman Advisors LLC now owns 40,855 shares of the conglomerate’s stock worth $9,051,000 after purchasing an additional 26,363 shares in the last quarter. Birch Hill Investment Advisors LLC increased its holdings in Danaher by 9.6% in the 3rd quarter. Birch Hill Investment Advisors LLC now owns 40,549 shares of the conglomerate’s stock worth $8,984,000 after purchasing an additional 3,553 shares in the last quarter. Finally, Forbes J M & Co. LLP increased its holdings in Danaher by 141.6% in the 3rd quarter. Forbes J M & Co. LLP now owns 4,276 shares of the conglomerate’s stock worth $947,000 after purchasing an additional 2,506 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 10.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on DHR shares. Robert W. Baird increased their target price on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research report on Thursday, October 22nd. Citigroup boosted their price target on Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Royal Bank Of Canada upped their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research note on Monday, October 5th. The Goldman Sachs Group reiterated a “buy” rating and issued a $275.00 price objective on shares of Danaher in a report on Thursday, October 22nd. Finally, DZ Bank lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Danaher Stock Performance

Shares of Danaher stock opened at $226.43 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $159.30 billion, a price-to-earnings ratio of 37.06, a P/E/G ratio of 2.95 and a beta of 0.76. The company’s fifty day moving average is $219.98 and its 200 day moving average is $201.62.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. The business had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. Danaher’s quarterly revenue was up 8.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.89 earnings per share. Sell-side analysts forecast that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is 26.19%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.